Cargando…
A systematic review of the efficacy of ketamine for craniofacial pain
BACKGROUND: Craniofacial pain (CFP) poses a burden on patients and health care systems. It is hypothesized that ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can reverse central sensitization associated with causation and propagation of CFP. This systematic review aims to assess the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294769/ https://www.ncbi.nlm.nih.gov/pubmed/37383673 http://dx.doi.org/10.1080/24740527.2023.2210167 |